Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety ...
Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
AML Watcher today announced the launch of TruRisk, an AI-powered screening agent designed to help compliance teams identify likely true positives faster while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results